Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group-Reference-Cited by-同舟云学术

Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group

Published:2010-11-22 Issue:1 Volume:86 Page:16-22
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Beksac Meral,Haznedar Rauf,Firatli-Tuglular Tulin,Ozdogu Hakan,Aydogdu Ismet,Konuk Nahide,Sucak Gulsan,Kaygusuz Işık,Karakus Sema,Kaya Emin,Ali Ridvan,Gulbas Zafer,Ozet Gulsum,Goker Hakan,Undar Levent

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2010.01524.x/fullpdf

Reference11 articles.

1. Italian Multiple Myeloma Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial. Network, GIMEMA;Palumbo;Lancet,2006

2. Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma;San Miguel;N Engl J Med,2008

3. Intergroupe Francophone du Myélome. Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial;Facon;Lancet,2007

4. Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial;Hulin;J Clin Oncol,2009

5. Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial;Palumbo;Blood,2008

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. At what point are we on the way to optimally treat multiple myeloma patients over 75 years of age in 2023?;Advances in Clinical and Experimental Medicine;2023-08-14

2. Treatment of Patients with Newly-Diagnosed Multiple Myeloma;Recent Updates on Multiple Myeloma;2023-03-15

3. Network meta‐analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant;Hematological Oncology;2022-07-11

4. Treatment Regimens for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis;Advances in Therapy;2022-03-05

5. Efficacy of first-line treatment options in transplant-ineligible multiple myeloma: A network meta-analysis;Critical Reviews in Oncology/Hematology;2021-12